Jon A Kobashigawa
Overview
Explore the profile of Jon A Kobashigawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
2078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuji M, Patel J, Kittleson M, Chang D, Kransdorf E, Nikolova A, et al.
Clin Transplant
. 2025 Mar;
39(3):e70124.
PMID: 40038060
Background: Heart re-transplantation (re-HT) is the last treatment option for end-stage graft failure, with cases due to severe cardiac allograft vasculopathy (CAV) showing a better prognosis compared to other indications....
2.
Hyun J, Youn J, Hong J, Kim D, Kim J, Kim M, et al.
J Korean Med Sci
. 2025 Jan;
40(3):e14.
PMID: 39834223
Background: Shortage of organ donors in the Republic of Korea has become a major problem. To address this, it has been questioned whether heart transplant (HTx) allocation should be modified...
3.
Jain R, Kransdorf E, Cowger J, Jeevanandam V, Kobashigawa J
JACC Heart Fail
. 2024 Nov;
13(3):389-401.
PMID: 39570235
The number of candidates on the waiting list for heart transplantation (HT) continues to far outweigh the number of available organs, and the donor heart nonuse rate in the United...
4.
Manla Y, Chang D, Patel J, Kanungo A, Nikolova A, Kransdorf E, et al.
J Heart Lung Transplant
. 2024 Nov;
PMID: 39561862
Background: Primary graft dysfunction (PGD) remains the leading cause of 30-day mortality post-heart transplantation (HTx). HTx recipients experiencing severe PGD have been found to have high levels of circulating proteins...
5.
Tsuji M, Patel J, Kittleson M, Chang D, Kransdorf E, Nikolova A, et al.
J Heart Lung Transplant
. 2024 Oct;
44(1):57-63.
PMID: 39369967
Background: Microvascular dysfunction after heart transplantation leads to restrictive cardiac allograft physiology (RCP), which is classified as severe coronary allograft vasculopathy (CAV); however, the prognosis of RCP remains unclear. Therefore,...
6.
Kim I, Starling R, Khush K, Passano E, Mirocha J, Bernhardt P, et al.
J Heart Lung Transplant
. 2024 Aug;
43(11):1788-1794.
PMID: 39089607
Background: Long-term clinical outcomes of early intravascular ultrasound (IVUS) findings in a prospective cohort of heart transplantation (HTx) patients have not been evaluated. Methods: This study included patients from 20...
7.
Zhang X, Reinsmoen N, Kobashigawa J
Transplantation
. 2024 Jul;
109(3):519-526.
PMID: 39049137
Background: The development of de novo donor-specific antibodies (dnDSA) and antibody-mediated rejection (AMR) remains a barrier to long-term graft and patient survival. Most dnDSA are directed against mismatched donor HLA-DQ...
8.
Nikolova A, Kobashigawa J
JACC Heart Fail
. 2024 Jul;
12(10):1689-1691.
PMID: 39023491
No abstract available.
9.
Kim I, Kim S, Youn J, Kim D, Lee S, Kim H, et al.
JACC Heart Fail
. 2024 Feb;
12(2):395-405.
PMID: 38326002
Background: Post-transplant lymphoproliferative disorder (PTLD) is an important cause of morbidity and mortality in heart transplant (HTx) recipients. However, previous studies of PTLD after HTx are limited to single-center analyses...
10.
Le J, Chang D, Kobashigawa J, Kittleson M
JACC Case Rep
. 2024 Jan;
28:102100.
PMID: 38204555
Coronary vasospasm is a rare complication after heart transplant. Due to denervation of the donor heart, patients are typically asymptomatic but may present with cardiac arrhythmias or cardiac arrest. We...